Condition (MeSH)
Micronuclei, Chromosome-Defective
ClinicalTrials.gov lists 1 trial for Micronuclei, Chromosome-Defective or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
5 sections measured, none recorded · 1 not measured yet · 1 not computed
1 of the 1 trial is tagged with Micronuclei, Chromosome-Defective itself; the rest are tagged with a narrower condition beneath it.
When did Micronuclei, Chromosome-Defective trials start? (1)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2018 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Micronuclei, Chromosome-Defective trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 1 |
How many Micronuclei, Chromosome-Defective trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Micronuclei, Chromosome-Defective? (20)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Micronuclei frequency in peripheral blood lymphocytes of healthy subjects living in turin (North-Italy): contribution of body mass index, age and sex. | Annals of human biology | 2020 | Yes |
| Chromosomal damage measured by the cytokinesis block micronucleus cytome assay in diabetes and obesity - A systematic review and meta-analysis. | Mutation research. Reviews in mutation research | 2020 | Yes |
| Evaluation of the potential of mobile phone specific electromagnetic fields (UMTS) to produce micronuclei in human glioblastoma cell lines. | Toxicology in vitro : an international journal published in association with BIBRA | 2017 | Yes |
| Potential uses, limitations, and basic procedures of micronuclei and nuclear abnormalities in buccal cells. | Disease markers | 2014 | Yes |
| The association of micronucleus frequency with obesity, diabetes and cardiovascular disease. | Mutagenesis | 2011 | Yes |
Showing 5 of 20 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.